Clinical characteristics of different histologic types of breast cancer

scientific article published on October 2005

Clinical characteristics of different histologic types of breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.BJC.6602787
P932PMC publication ID2361680
P698PubMed publication ID16175185
P5875ResearchGate publication ID7589096

P50authorJanet DalingQ20807295
P2093author name stringC I Li
D J Uribe
P2860cites workInfiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcomeQ21092905
Postmenopausal estrogen and progestin use in relation to breast cancer riskQ34525017
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.Q40497303
A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breastQ40522832
Experience with lobular carcinoma of the breast. Emphasis on recent aspects of managementQ41541827
Age distribution of histologic types of breast carcinomaQ43952114
Relationship between long durations and different regimens of hormone therapy and risk of breast cancerQ44489759
Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.Q44677780
Hormone receptor status of breast cancer in India: a study of 798 tumoursQ47255446
Trends in incidence rates of invasive lobular and ductal breast carcinomaQ47403953
Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 YearsQ47444766
Misclassification bias related to definition of menopausal status in case-control studies of breast cancerQ52860364
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)Q57268418
Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities?Q60148921
Infiltrating lobular carcinoma of the breastQ70338114
Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77Q70919678
Tumor biology of infiltrating lobular carcinoma. Implications for managementQ71779435
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?Q72359886
Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factorsQ72825296
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged womenQ73911298
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profileQ75344740
Hormone replacement therapy in relation to breast cancerQ77651681
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
P304page(s)1046-1052
P577publication date2005-10-01
P1433published inBritish Journal of CancerQ326309
P1476titleClinical characteristics of different histologic types of breast cancer
P478volume93

Reverse relations

cites work (P2860)
Q45401326A Low-Cost, Low-Skill Model for Efficient Breast Cancer Screening in Low Resource Rural Settings of a Developing Country
Q63366126A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer
Q50318351A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy: a case report.
Q58834538A study of ductal versus non-ductal invasive breast carcinomas in older women: long-term clinical outcome and comparison with their younger counterparts
Q38186556Aberrant DNA methylation of microRNA genes in human breast cancer - a critical appraisal
Q34467216Absence of microsatellite instability in mucinous carcinomas of the breast.
Q53599257Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years.
Q34230233Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics
Q34132812Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study
Q36021686Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype
Q58604437Breast Cancer in Basra Oncology Center: A Clinico- Epidemiological Analysis
Q92916943Breast Cancer: Current Perspectives on the Disease Status
Q35370118Breast cancer - one term, many entities?
Q37602561Breast cancer in systemic lupus erythematosus
Q37551363Breast carcinoma--rare types: review of the literature
Q92989260Cadmium Exposure and Risk of Breast Cancer by Histological and Tumor Receptor Subtype in White Caucasian Women: A Hospital-Based Case-Control Study
Q48180862Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast.
Q89847095Characteristics of Special Type Breast Tumors in Our Center
Q92890042Characterization of Kelch domain-containing protein 7B in breast tumours and breast cancer cell lines
Q31140585Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
Q38431284Clinical management of breast cancer heterogeneity
Q40135743Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
Q57815796Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study
Q36032521Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study
Q44415353Clinicopathological characteristics and prognosis of mucinous breast carcinoma
Q33680221Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified
Q91692229Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database
Q36908141Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
Q37244058Comparison of clinicopathological characteristics of lymph node positive and lymph node negative breast cancer
Q89529839Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study
Q37484662Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma.
Q90599833Correlation between apparent diffusion coefficient values in breast magnetic resonance imaging and prognostic factors of breast invasive ductal carcinoma
Q35172218Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D
Q89686492DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer
Q37225635Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database
Q36415430Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
Q64234735Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas
Q45059731Does primary breast cancer in older women (≥80 years) have unfavorable histological characteristics?
Q93010229Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
Q90430465Effectivity of combined diffusion-weighted imaging and contrast-enhanced MRI in malignant and benign breast lesions
Q33833475Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells
Q57107109Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti
Q36611606Established breast cancer risk factors by clinically important tumour characteristics
Q48364519Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients
Q37631744Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.
Q33898676Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma
Q51609262Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
Q84907028Expression of metalloproteases and their inhibitors in different histological types of breast cancer
Q53687423Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women.
Q35421375Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
Q34733888Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer
Q53276495Expression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breast.
Q57105820F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men
Q39122509FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer
Q43272689Fischer's score criteria correlating with histopathological prognostic factors in invasive breast cancer.
Q34518541G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis
Q47558826Her-2 positive mucinous carcinoma breast cancer, case report
Q41297799High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer
Q33584230Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway
Q57307176Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences
Q34616569Histological, molecular and functional subtypes of breast cancers
Q34572280Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis
Q35749359Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
Q38241276Illuminating breast cancer invasion: diverse roles for cell-cell interactions
Q37300556Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study.
Q36128930Infiltrating lobular carcinoma of the breast presenting as gastrointestinal obstruction: a mini review
Q35890623Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction
Q44536037Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique?
Q56999072Integrated analysis of dysregulated lncRNA expression in breast cancer cell identified by RNA-seq study
Q60935039Integration of Cancer Registry Data into the Text Information Extraction System: Leveraging the Structured Data Import Tool
Q35743495Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study
Q50227670Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
Q54649194Invasive Lobular Breast Cancer: Does Grade Matter?
Q42518349Invasive breast cancer: a significant correlation between histological types and molecular subgroups
Q37209538Invasive ductal carcinoma of the breast with osteoclast-like giant cells and clear cell features: a case report of a novel finding and review of the literature
Q37531363Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast
Q55396783Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism.
Q40061357Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma
Q34179808Late age at first full term birth is strongly associated with lobular breast cancer
Q35170028Lobular breast cancer: incidence and genetic and non-genetic risk factors
Q89941347Lobular breast carcinoma metastatic to the endometrium in a patient under tamoxifen therapy: A case report
Q92646038Low nuclear zinc finger and BTB domain containing 7A expression is an independent prognostic factor for recurrence-free survival in invasive ductal carcinoma of the breast
Q33307561MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature
Q40171298Mammographic and ultrasound features of invasive lobular carcinoma of the breast
Q36251444Management of unusual histological types of breast cancer
Q90476180Medullary Breast Carcinoma and Invasive Ductal Carcinoma: A Review Study
Q57107113Metastatic Breast Cancer Presenting As Orbital Mass: A Case Report With Literature Review
Q59465999Microfluidics: Rapid Diagnosis for Breast Cancer
Q34086486Microtubule-associated protein Mdp3 promotes breast cancer growth and metastasis
Q90286878Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade
Q41605699Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status
Q37708047Molecular Classification of Lobular Carcinoma of the Breast
Q33799226Mucinous breast cancer - clinical characteristics and treatment results in patients treated at the Oncology Centre in Kraków between 1952 and 2002
Q51549423Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer.
Q42450636Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women
Q36422503New primary ipsilateral metachronous breast tumor: a case report
Q55025978Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery.
Q92431904PREDICTIVE CIRCULATING MARKERS FOR ANTHRACYCLINE CHEMOTHERAPY IN NON-METASTATIC BREAST CANCER
Q26769704Papillary carcinoma of breast: Minireview
Q37222882Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment.
Q38101747Pitfalls in outcome prediction of breast cancer.
Q90476371Presence of circulating tumor cells is associated with metabolic-related variables in postoperative patients with early-stage breast cancer
Q38319569Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome.
Q35840060Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population
Q101403266Prognostic and predictive parameters in breast pathology: a pathologist's primer
Q40471089Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers.
Q91586076Quantitative assessment of Ki67 expression in correlation with various breast cancer characteristics and survival rate; cross sectional study
Q47355574Rapid virtual hematoxylin and eosin histology of breast tissue specimens using a compact fluorescence nonlinear microscope.
Q64045407Rare breast neoplasms: is there any peculiar feature on magnetic resonance mammography?
Q43693997Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast
Q33693138Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.
Q33876067Relationship among mammographic findings with histopathologic type of breast cancer and human epidermal growth factor receptor 2 (HER2) in young women
Q35013079Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis
Q37135273Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis
Q37120162Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer
Q48328328Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
Q89966634Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system
Q34613642Risk factors for ductal and lobular breast cancer: results from the nurses' health study
Q33903091Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population
Q37055548Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study
Q35750765Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry
Q84563118Risk of mortality by histologic type of breast cancer in the United States
Q88723009Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the Breast
Q91713420Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target
Q90072180Structured light imaging for breast-conserving surgery, part I: optical scatter and color analysis
Q38834039Survival differences of CIMP subtypes integrated with CNA information in human breast cancer
Q47552011Synchronous Uterine Metastases from Breast Cancer: Case Study and Literature Review
Q38944944The CpG island methylator phenotype in breast cancer is associated with the lobular subtype
Q60951040The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes
Q99629722The Impact of Preoperative Breast Magnetic Resonance Imaging on Surgical Management in Symptomatic Patients With Invasive Lobular Carcinoma
Q92757846The Role of ZNF143 in Breast Cancer Cell Survival Through the NAD(P)H Quinone Dehydrogenase 1⁻p53⁻Beclin1 Axis Under Metabolic Stress
Q57472254The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer
Q51747356The combined association of modifiable risk factors with breast cancer risk in the Women's Health Initiative.
Q36810356The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms
Q33761874The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study
Q39175548The molecular basis of breast cancer pathological phenotypes
Q39703687Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Q38997433Treatment choices for patients with invasive lobular breast cancer: a doctor survey
Q55518016Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
Q33852544Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature
Q36411711Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population
Q40382207Uncovering Professional Attitudes Toward Treatment of Rare Carcinomas of the Breast: An International Practice e-Survey Involving 32 Countries
Q30454418Unusual aggressive breast cancer: metastatic malignant phyllodes tumor
Q33808614Unusual primary breast cancer - malignant peripheral nerve sheath tumor: a case report and review of the literature
Q36593545Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer
Q47609280Zinc finger protein 143 expression is closely related to tumor malignancy via regulating cell motility in breast cancer
Q91831588[Diagnostic and therapeutic features of invasive lobular carcinoma of the breast: a study of 30 cases]
Q57129131[Lobular neoplasms and invasive lobular breast cancer]

Search more.